Although the effectiveness of two vaccinations was confirmed in the present study, the current findings also showed that, in PIBD patients on anti-TNFα, antibody concentrations were lower and attenuated more rapidly over time than those treated with other IBD medications after the initial two-vaccine series. This evidence concerns the gene TNF and inflammatory bowel disease.